Saint John’s Cancer Institute is renowned research facility dedicated to advanced therapeutics, translational sciences, and best medical practices. We promote robust fellowship programs and clinical trials, collaborating with industry and academic partners worldwide.
Read MoreSaint John’s Cancer Institute (SJCI) is a pioneer in drug discovery, therapeutics, and clinical trials. SJCI conducted the research that established the Sentinel Lymph Node Biopsy under the late Dr. Donald L. Morton, which has become the standard of lymph node care for melanoma and breast cancer worldwide. Today, our patients continue to have access to innovative treatments, therapeutics, and trials. We are at the forefront of understanding the biology of cancer as well as expanding treatment for under-served communities.
Learn More“We have had prior evidence that it may have anti-cancer activity in patients with early-stage prostate cancer.”
– Przemyslaw Twardowski, M.D.
“This team has a tremendous opportunity to create solutions that can be used as national models for integrated colorectal cancer outreach and screening.”
– Anton Bilchik, M.D.
“We are now one of the only centers in the Southwest and Westcoast to offer this new procedure for patients.”
– Melanie GoldFarb, M.D.
